Coffee can be good for you (Science News, Sep 21, 2015) | Neuroscience and the insanity defense (Inverse, Sep 18, 2015) | Brain eating amoeba? (Science News, Jul 28, 2015) | Boosting brain estrogen (Science News, Jul 24, 2015) | How the brain keeps time (ScienceNews, Jul 20, 2015) | Teen brains and dopamine (Medical Express, Jul 07, 2015) | The science of oxytocin (Nature, Jul 06, 2015) | “Inside out” movie animates emotions (NBC News, Jul 06, 2015) | Is creativity linked to psychosis? (Nature, Jul 06, 2015) | Is porn really addicting? (Shape, Jul 06, 2015) | Drunk with love? (The Telegraph, May 26, 2015) | Potential trigger for schizophrenia (Science Daily , Apr 09, 2015) | The Neuroscience of Jimi Hendrix (Forbes, Mar 16, 2015) | How to keep your brain from shrinking (EurekAlert, Mar 05, 2015) | Neuroscience of marijuana munchies (The Scientist, Feb 23, 2015) | The neuroscience of freestyle rap (Medical Daily , Feb 23, 2015) | The psychopharmacology of love (Salon, Feb 23, 2015) | Peptide controls binge eating (Futurity , Feb 23, 2015) | At-home brain stimulation (Science News, Nov 03, 2014) | Chocolate boosts aging brains (Science News, Oct 28, 2014) | Balancing the excitation in depression (Science News, Sep 29, 2014) | Neuroscience of Emoticons (Fast Co Design, Aug 11, 2014) | Doodling affects your brain (Wall Street Journal, Aug 04, 2014) | We use just 10% of our brains? (Quartz, Jul 28, 2014) | Marijuana use decreases dopamine (Science News, Jul 22, 2014) | Is love addicting? (Psych Central, Jul 20, 2014) | Scientists stop worms from getting drunk (University of Texas, Jul 20, 2014) | About that brain decoder... (BBC, Jul 20, 2014) | Stress, Age, and Memory (IowaNow, Jun 23, 2014) | Stress and your brain (Science News, Jun 09, 2014) | Brain area imparts resilience (Washington Post, Jun 09, 2014) | Bilingualism Benefits Aging Brain (Sci-News, Jun 09, 2014) | Your brain in 2050 (Inc, Jun 04, 2014) | Are you getting enough sleep? (The Telegraph , May 17, 2014) | Why you don't remember being a baby (Science News, May 13, 2014) | Dogs get anxiety too (The Atlantic, May 09, 2014) | Potential drug for cocaine addiction (, May 02, 2014) | A man with amnesia (Muskogee Phoenix, Apr 14, 2014) | Green tea boosts your brain (Science Codex, Apr 14, 2014) | The Neuroscience of Art (ULoop, Apr 14, 2014) | Neuroscience of color (Fast Company, Mar 25, 2014) | Caffeine-like drugs (Bloomberg, Mar 25, 2014) | Tuning the brain (Nature, Mar 24, 2014) | 10 things wrong about anxiety (Huffington Post, Mar 17, 2014) | NIH rethinks psychiatry trials (Nature, Mar 17, 2014) | The neuroscience of leadership (CIO, Mar 10, 2014) | Why some people don’t like music (PolicyMIC, Mar 10, 2014) | Why remember dreams? (Medical Xpress, Feb 24, 2014) | How brains see music (The Atlantic, Feb 24, 2014) | Does Caffeine Boost Memory? (Science News, Jan 20, 2014) | Most Realistic Movie Psychopaths (Science News, Jan 20, 2014)

ACNP Spotlight


The 54th Annual Meeting is December 6-10 at the Diplomat Resort in Hollywood, Florida. Meeting registration and poster abstract submissions are open.  Please remember, those wishing to submit a poster abstract must first register for the meeting. The Program Committee met in Chicago on July 11th and the 2015 program has been selected. All chairs have been notified of acceptance decisions and all sessions have been scheduled. Read more

2015 Annual Meeting Preliminary Schedule

American Psychiatric Association (APA)draft practice guideline on the use of antipsychotics to treat agitation and psychosis in patients with dementia.  Review and comment deadline September 19, 2015.

Minority Task Force Report on Initiatives  

ACNP 2015 President's Letter- Dr. Raquel E. Gur, Time to Contemplate and Innovate.

54th Annual Meeting: Hollywood, Florida December 6-10, 2015

2015 Annual Meeting Childcare

Annual Meeting FAQs

Neuropsychopharmacology Reviews - Neurodevelopment and the Origins of Brain Disorders

The Cure Alliance for Mental Illness petition to promote research for mental illness  

NPP Podcast
Brain changes in young smokers
The value of alcohol

NIMH Directors Blog
NIDA Directors Blog

Neuro News Corner

Article- With flibanserin approval, a complicated drug takes the spotlight

Ever since Viagra was first approved for men, female advocates have been waiting for their “little pink pill.” On August 18, the day arrived: Flibanserin — a failed antidepressant — received approval from the Food and Drug Administration to boost sexual desire in women. Immediately articles and blog posts were published that questioned the new drug. Some noted its low efficacy and interactions with alcohol and with other medications, and cast a leery eye at the strong advocacy associated with the drug’s approval. Supporters and some patients praised the decision, saying it opened the door for other companies to develop alternatives.

Flibanserin, soon to be marketed as Addyi, has been in clinical trials to treat low desire since the mid-2000s. It has been previously rejected by the FDA, once in 2010 over concerns of its efficacy and once again in 2013, when the FDA questioned whether the side effect risks outweighed the benefits. Sprout Pharmaceuticals appealed the decision and after additional safety studies, the drug finally got approval. - Read More (Source - Science News, Images- Sprout Pharmaceuticals)


The New Science of How to Quit Smoking, as shown in a recent Neuropsychopharmacology research article.  

Mechanism of action of two new synthetic drugs unravelled for the first timeas shown in recent Neuropsychopharmacology research article. 

Omega-3 fatty acids help improve boys' attention spans, as shown in recent Neuropsychopharmacology research article.  

Welcome to the ACNP website

Welcome to the website of the American College of Neuropsychopharmacology (ACNP), a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.


About the CoverWith a 2013 impact factor of 7.833 NPP ranks 8th of 135 Psychiatry journals, 8th of 260 Pharmacology and Pharmacy journals, and 17th of 251 Neuroscience journals. 97% of accepted articles are published online in less than 25 business days and in print in less than 71 business days. In 2013, all issues of Neuropsychopharmacology were published on or ahead of schedule. SUBMIT YOUR ARTICLE HERE.

NPP Reviews

NPP ReviewPublished each January as a special collection of review articles, the 2015 issue of NPPR addresses Neurodevelopment and the Origins of Brain Disorders.  Neuropsychopharmacology Reviews